论文部分内容阅读
化学抗癌药物结合参麦液治疗非小细胞性肺癌,结果提示,结合参麦液治疗组有效率为67.6％,而对照组为42.1%,二组对比差异显著(P<0.05);结合参麦液组化疗期间的毒副反应也较对照组轻。说明化疗结合参麦液治非小细胞性肺癌有可能提高临床疗效,减少化学抗癌药物的毒副反应。
Chemical anti-cancer drugs combined with Shenmai liquid in the treatment of non-small cell lung cancer, the results suggest that the effective rate of combined Shenmai solution treatment group was 67.6%, while the control group was 42.1%, the difference between the two groups was significant (P<0.05); The toxicity of the wheat liquid group during chemotherapy was also lighter than that of the control group. It is suggested that the combination of chemotherapy and Shenmai Solution in the treatment of non-small cell lung cancer may improve the clinical efficacy and reduce the toxic and side effects of chemical anticancer drugs.